ABSTRACT
Speed read Researchers are working on possible mRNA vaccines for TB, malaria, and HIV Technology shows potential but needs further exploration Global South production would be crucial to ensure equal access While researchers are still in the early stages of development for new mRNA vaccines, global health leaders focused on the world’s most neglected infectious diseases say that conversations about access should begin now. The World Health Organization (WHO) has announced that mRNA technology transfer hubs will be set up in six African countries, with ‘spokes’ in other low- and middle-income countries. “Government and other public or not-profit organisations which finance research should ensure that their funding prioritises public health at large over profits for the private sector, and that IP rights are managed in a way which allows low- and middle-income countries to manufacture their own vaccines,” adds Kieny.